These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7615793)

  • 1. Mevalonate availability affects human and rat resistance vessel function.
    Roullet JB; Xue H; Roullet CM; Fletcher WS; Cipolla MJ; Harker CT; McCarron DA
    J Clin Invest; 1995 Jul; 96(1):239-44. PubMed ID: 7615793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mevalonate availability and cardiovascular functions.
    Roullet JB; Xue H; Pappu AS; Roullet C; Holcomb S; McCarron DA
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11728-32. PubMed ID: 8265617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat.
    Alvarez De Sotomayor M; Herrera MD; Marhuenda E; Andriantsitohaina R
    Br J Pharmacol; 2000 Nov; 131(6):1179-87. PubMed ID: 11082126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beneficial in vitro effects of lovastatin and chelerythrine on relaxatory response to acetylcholine in the perfused mesentric bed isolated from diabetic rats.
    Fatehi-Hassanabad Z; Imen-Shahidi M; Fatehi M; Farrokhfall K; Parsaeei H
    Eur J Pharmacol; 2006 Mar; 535(1-3):228-33. PubMed ID: 16516190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes.
    Elfakhani M; Torabi S; Hussein D; Mills N; Verbeck GF; Mo H
    Exp Biol Med (Maywood); 2014 Mar; 239(3):293-301. PubMed ID: 24477821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Hydroxy-3-methyl glutaryl coenzyme A reductase inhibition modulates vasopressin-stimulated Ca2+ responses in rat A10 vascular smooth muscle cells.
    Ng LL; Davies JE; Wojcikiewicz RJ
    Circ Res; 1994 Feb; 74(2):173-81. PubMed ID: 8293556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin inhibits interferon-gamma-induced Trypanosoma brucei brucei proliferation: evidence for mevalonate pathway involvement.
    Andersson M; Löw P; Bakhiet M
    J Interferon Cytokine Res; 1996 Jun; 16(6):435-9. PubMed ID: 8807496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
    Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
    J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mevalonate reverses the developmental arrest of preimplantation mouse embryos by Compactin, an inhibitor of HMG Co A reductase.
    Surani MA; Kimber SJ; Osborn JC
    J Embryol Exp Morphol; 1983 Jun; 75():205-23. PubMed ID: 6886611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
    Straka MS; Panini SR
    Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The length of 5'-untranslated leader sequences influences distribution of 3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in polysomes: effects of lovastatin, oxysterols, and mevalonate.
    Gayen AK; Peffley DM
    Arch Biochem Biophys; 1995 Oct; 322(2):475-85. PubMed ID: 7574724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin inhibits proliferation of rat mesangial cells.
    O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
    J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
    Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
    Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
    Choi JW; Jung SE
    J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fluvastatin on structure and function of resistant vessels in spontaneously hypertensive rats.
    Lin ZH; Xie LD; Wu KG; Wang HJ; Xu CS
    Zhongguo Yao Li Xue Bao; 1999 Sep; 20(9):855-60. PubMed ID: 11245097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
    Escobales N; Crespo MJ; Altieri PI; Furilla RA
    J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cholesterol-enriched diet and the mevalonate pathway in cardiac nitric oxide synthesis.
    Giricz Z; Csonka C; Onody A; Csont T; Ferdinandy P
    Basic Res Cardiol; 2003 Sep; 98(5):304-10. PubMed ID: 12955403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for mevalonate in cycling cells: quantitative and temporal aspects.
    Doyle JW; Kandutsch AA
    J Cell Physiol; 1988 Oct; 137(1):133-40. PubMed ID: 3170653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.